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Abstract: Human cells, when exposed to both real and simulated microgravity (s-µg), form 3D
tissue constructs mirroring in vivo architectures (e.g., cartilage, intima constructs, cancer spheroids
and others). In this study, we exposed human foetal osteoblast (hFOB 1.19) cells to a Random
Positioning Machine (RPM) for 7 days and 14 days, with the purpose of investigating the effects of
s-µg on biological processes and to engineer 3D bone constructs. RPM exposure of the hFOB 1.19
cells induces alterations in the cytoskeleton, cell adhesion, extra cellular matrix (ECM) and the 3D
multicellular spheroid (MCS) formation. In addition, after 7 days, it influences the morphological
appearance of these cells, as it forces adherent cells to detach from the surface and assemble into
3D structures. The RPM-exposed hFOB 1.19 cells exhibited a differential gene expression of the
following genes: transforming growth factor beta 1 (TGFB1, bone morphogenic protein 2 (BMP2),
SRY-Box 9 (SOX9), actin beta (ACTB), beta tubulin (TUBB), vimentin (VIM), laminin subunit alpha 1
(LAMA1), collagen type 1 alpha 1 (COL1A1), phosphoprotein 1 (SPP1) and fibronectin 1 (FN1). RPM
exposure also induced a significantly altered release of the cytokines and bone biomarkers sclerostin
(SOST), osteocalcin (OC), osteoprotegerin (OPG), osteopontin (OPN), interleukin 1 beta (IL-1β)
and tumour necrosis factor 1 alpha (TNF-1α). After the two-week RPM exposure, the spheroids
presented a bone-specific morphology. In conclusion, culturing cells in s-µg under gravitational
unloading represents a novel technology for tissue-engineering of bone constructs and it can be used
for investigating the mechanisms behind spaceflight-related bone loss as well as bone diseases such
as osteonecrosis or bone injuries.
Keywords: osteoblasts; bone; tissue engineering; simulated microgravity; biomarker; cytoskeleton
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1. Introduction
Real microgravity in space can affect the health of astronauts after an extended period of time
on the international space station (ISS) or other future platforms allowing a sojourn in orbit [1].
Therefore, space life-science research has been initiated, with hopes to enable humans to undertake
long-term space explorations. Studies of terrestrial organisms exposed to real (r-µg) or simulated
microgravity (s-µg) face multiple challenges, as even experiments with cells under r-µg conditions
are rather rare and expensive. For this reason, researchers have developed simulation devices, such
as the 2D clinostat (CN), the NASA-developed rotating wall vessel (RWV) bioreactor, the random
positioning machine (RPM) and the magnetic levitator, among others, to prepare for spaceflights and to
conduct ground-based space research on stem cells and specialized cells [1–3]. RPMs are like clinostats
or rotating wall vessel bioreactors, ground-based facilities constructed to simulate microgravity on
the Earth’s surface (1 g). Their working principle is based on a gravity vector averaging to zero
over time [4]. The cell samples are placed on the inner frame, where they are constantly reoriented;
meanwhile, 1 g is always acting on the samples. The gravity vector needs to point in a specific direction
for a short time period only, without acceleration of cell sedimentation. As the gravity vector averages
to zero, the cells experience a state similar to microgravity. Mesland [5] proposed that the frame
rotations should be faster than the investigated biological processes. Moreover, the rotation cannot
be too fast, as centrifugal forces will become effective [6]. It is known that the use of an RPM induces
additional forces on the cells, through the special moving pattern. It is important to mention that,
when the RPM is operated within certain boundaries, these forces can be attenuated to a minimum [7].
The RPM is used worldwide for tissue-engineering purposes for various cell types and is an accepted
model in preparing for future spaceflight missions [1,8].
In vitro studies on different types of human renal cortical cells or mouse MC3T3 osteoblasts in
space or on microgravity simulating devices, have demonstrated significant changes in gene expression
patterns [9,10], increased apoptosis (ML1 follicular thyroid cancer cells, glial cells, MDA-MB231 breast
cancer cells and human lymphocytes (Jurkat)) [11–14] and induction of autophagy (human umbilical
vein endothelial cells, HEK293 cells) [15,16], as well as changes in differentiation (FTC-133 follicular
thyroid cancer cells) [17], migration, cell adhesion, extracellular matrix composition (ML1 cells) [11]
and alterations in the cytoskeleton (FTC-133 cells, A431 epidermoid carcinoma cells) [18,19].
Magnetic levitation of mouse calvarial MC3T3 osteoblast cells was used as a ground-based simulation
of microgravity [10]. The cells were grown on cytodex-3 beads and cultured in a superconducting magnet
for 2 days, which resulted in marked alterations in gene expression. Gravitational stress leads to up- and
down-regulation of hundreds of genes [10]. Random rotation and magnetic levitation induced similar
changes in the actin cytoskeleton of A431 cells, which were also described in r-µg [19].
Interestingly, it was found that tissue cells switch, in space, from a two-dimensional (2D)
monolayer growth to a three-dimensional (3D) growth, into a tissue-like construct [20]. Tissue
engineering in space and the application of microgravity simulation techniques is a new topic in
translational regenerative medicine. Knowledge of the mechanisms of 3D growth in human cells
is very important for advancing the processes of tissue engineering. Various cells exposed to the
special environment of r-µg and s-µg conditions have already been characterized. Some examples
of growing tissues from specialized cells in microgravity are: Multicellular tumour spheroids from
various tumour types (MDA-MB231 and MCF-7 breast cancer cells, as well as FTC-133, ML1 and
RO82-W-1 follicular thyroid cancer cells) [13,21–25], artificial vessel constructs (EA.hy926 endothelial
cells) [26,27], regenerated cartilage (primary human chondrocytes) [28,29] or bone tissues (human
pre-osteoblastic cells, human mesenchymal pre-osteoblastic cells) [30,31].
Tissue engineering of bone tissue is of high importance in regenerative medicine. The incidence
of bone disorders worldwide is continuously increasing, due to aging populations combined with
obesity and reduced physical activity [32]. The loss of skeletal tissue can accompany trauma, injury
and disease. Treatment strategies include the use of stem cells, specialized cells, novel scaffolds and
growth factors to improve the bone formation process [1]. Tissue-engineered bone fragments from
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new-born rat calvarial cells might serve as a potential alternative to the conventional use of bone grafts,
as pioneered by Su et al. [33] and Hidaka et al. [34] in animal models.
By the application of s-µg methods, several preliminary studies suggested the use of osteoblast
precursor or stem cells to be most suitable for the engineering of bone fragments [35]. Pre-osteoblasts,
from HEPM-1460 cells, cultured in an RWV could be engineered into osseous-like tissue [30,31].
Clarke et al. designed a new method for engineering bone constructs by culturing primary osteoblasts
and osteoclast precursors on a special bioreactor. This high-aspect ratio vessel (HARV) culture system
provided randomized gravity vector conditions and a low-shear stress environment [36].
This study aims to tissue-engineer bone constructs by exposing the fast-growing foetal human
osteoblasts of the hFOB 1.19 cell line—a well-characterized, stable osteoprogenitor and a widely used
model for normal osteoblast differentiation [37,38]—to the RPM. Using this new method, we intend
to increase our knowledge about the biology of foetal osteoblasts and to understand the effects of
RPM-exposure on hFOB 1.19 cells, as indicated by differentially expressed genes and changes in
protein secretion, as compared to the static 1 g conditions. The next step is to develop ideal bone grafts
for future applications in translational studies and, subsequently, in clinical applications.
2. Results
2.1. Morphological Examination of RPM-Exposed hFOB 1.19 Cells Reveal Signs of Organoid Formation
We detected two distinct growth patterns of hFOB 1.19 cells, exposed to simulated microgravity
on an RPM for 7 days and 14 days, respectively. Human foetal osteoblasts grow in adherent
monolayers (AD) during exposure to static 1 g conditions (for 7 days and 14 days) as shown by
standard phase-contrast imaging (see Figure 1A,B). In contrast, two different hFOB 1.19 populations
are distinguishable in s-µg. Within the same culture flask, one group of the cells developed in the form
of an adherent monolayer and the other group formed several 3D bone constructs or multicellular
spheroids (MCS). These cells had detached from the monolayer and assembled into bone-like cell
aggregates (see Figure 1C,D). The MCS presented an increase in size and number after 14 days of RPM
exposure (see Figure 1D), as compared to 7 days RPM samples (see Figure 1C). While the bone-like
constructs were observed in sizes up to 0.5 mm in length and 0.4 mm in width after 14 days, the
biggest MCS was 0.2 mm in diameter after 7 days (see Figure 1F). Furthermore, using phase contrast
microscopy (at magnification ×100), three times more MCS per field of view were seen on day 14,
as compared to day 7 (the numbers in the inserts in Figure 1E–G). The MCS were either distributed
anchorage-independently throughout the cultivation medium or found to be partially attached to the
adherent monolayer. There were no MCS detectable at 7 days (Figure 1A) and 14 days (Figure 1B) in
the 1 g control samples.
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2.2. Alterations of the Cytoskeleton and the Extracellular Matrix
Changes in cell morphology depend on foregoing alterations in cytological architecture.
Cytoskeletal changes are broadly acknowledged as the cause of bone loss in microgravity [40] and
for organoid formation in bone tissue engineering [41].
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2.2. Alterations of the Cytoskeleton and the Extracellular Matrix
Changes in cell morphology depend on foregoing alterations in cytological architecture.
Cytoskeletal changes are broadly acknowledged as the cause of bone loss in microgravity [40] and for
organoid formation in bone tissue engineering [41].
Immunofluorescence was performed to elucidate the cytoskeletal changes of β-tubulin. F-actin
was visualized by means of rhodamine-phalloidin staining. Well-organized F-actin filaments were
observed under static 1 g conditions, for 7 days and 14 days of cultivation (Figure 3A,C). Following
RPM exposure, a decrease in F-actin filaments was observed (Figure 3B,D). A shift in the microfilament
distribution towards F-actin accumulation at the cell boundaries was clearly noticeable in both the
7 days and 14 days RPM samples. The 3D aggregates contained outer cell membranes with F-actin
deposits (Figure 3B,D). MCS formation was visible. Filopodia and lamellipodia were detectable in
the RPM-exposed samples. ACTB mRNA expression was significantly elevated in both 7 days RPM
samples
andSci.
further
in the 14 days MCS samples (Figure 3I, Table 1).
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x
7 of 25

Figure
3. Influence
simulatedmicrogravity
microgravity on
on the
the cytoskeleton
osteoblasts.
Phalloidin–
Figure
3. Influence
of of
simulated
cytoskeletonofofhuman
human
osteoblasts.
Phalloidin–
rhodamine
staining
visualized
theF-actin
F-actindistribution
distribution in
cells
(A,C)
andand
RPM-exposed
rhodamine
staining
visualized
the
in the
the11ggcontrol
control
cells
(A,C)
RPM-exposed
(B,D).
yellowarrows
arrowsindicate
indicate filopodia
as well
as the
of F- of
cellscells
(B,D).
TheThe
yellow
filopodiaand
andlamellipodia,
lamellipodia,
as well
asaccumulation
the accumulation
actin at the outer cellular membranes. (E–H) Tubulin immunofluorescence: Red arrows indicate holes
F-actin at the outer cellular membranes. (E–H) Tubulin immunofluorescence: Red arrows indicate
in the tubulin network in spheroids. Gene expression of selected cytoskeletal genes: (I) β-actin (ACTB),
holes in the tubulin network in spheroids. Gene expression of selected cytoskeletal genes: (I) β-actin
(J) β-tubulin (TUBB) and (K) vimentin (VIM). Intracellular protein levels. (L) β-actin, (M) β-tubulin
(ACTB), (J) β-tubulin (TUBB) and (K) vimentin (VIM). Intracellular protein levels. (L) β-actin, (M)
and (N) vimentin. All values are given as mean ± standard deviation. # p < 0.05 1 g vs. AD; * p < 0.05 1
β-tubulin and (N) vimentin. All values are given as mean ± standard deviation. # p < 0.05 1 g vs. AD;
g vs. MCS. Scale bars: 20μm, d, days.
* p < 0.05 1 g vs. MCS. Scale bars: 20 µm, d, days.

In accordance with F-actin, the tubulin distribution was well-organized, as expected, in the 1 g
samples (Figure 3E). In the 7 days RPM samples, an elevated amount of tubulin protein was found
in the 3D aggregates and a more intense fluorescence in the RPM-AD samples (Figure 3F).
In addition, the tubulin microtubule expression was similar in the 1 g controls (Figure 3G). The
14 days MCS revealed holes in the tubulin cytoskeleton of the MCS samples (Figure 3H). The TUBB
mRNA levels were significantly increased in both 7 days RPM samples; whereas, after 14 days, TUBB
remained significantly elevated in the RPM-AD samples (Figure 3J, Table 1). Moreover, we
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Table 1. Changes in gene expression, protein levels and secretion behaviour.
mRNA Levels [% of 1 g Control]
Gene
ACTB

BMP2

COL1A1

FN1

SPP1

LAMA1

MKI67

SOX9

TGFB1

TUBB

VIM

1g

100.0
± 11.0

100.0
± 6.7

100.0
±
24.3

100.0
± 10.8

100.0
± 14.8

100.0
± 3.6

100.0
± 20.6

100.0
± 20.8

100.0
± 12.1

100.0
± 15.1

100.0
± 7.2

AD

N181.2
± 2.9

H45.6
± 9.7

124.0
± 6.0

N127.8
± 6.2

N1094.0
± 89.0

N197.3
± 18.4

111.4
± 10.3

N160.1
± 10.1

123.2
± 3.5

N297.4
± 27.8

N162.3
± 8.5

MCS

N154.7
± 19.7

N207.2
± 69.9

112.6
±
41.7

218.5
± 73.9

N1719.2
± 709.5

N244.4
± 67.0

89.0
± 35.9

140.1
± 51.6

147.1
± 32.3

N236.2
± 74.5

N166.7
± 38.5

1g

100.0
± 8.6

100.0
± 32.1

100.0
± 8.6

100.0
± 3.6

100.0
± 3.4

100.0
± 11.5

100.0
± 9.6

100.0
± 8.1

100.0
± 3.8

100.0
± 11.3

100.0
± 11.1

AD

113.1
± 25.8

H28.8
± 6.5

N234.0
± 5.3

N119.8
± 2.7

N813.4
± 22.2

127.9
± 8.1

132.1
± 9.5

N151.2
± 5.9

N133.8
± 4.0

N125.7
± 4.8

H76.1
± 3.5

MCS

225.2
± 61.7

100.1
± 43.8

225.7
±
11.4

107.7
± 7.0

1098.2
± 11.3

148.9
± 17.6

109.7
± 5.8

108.0
± 4.3

87.7
± 0.7

67.3
± 2.7

72.1
± 1.7

Sample

7 days

14 days

Intracellular Protein Levels [% of 1 g Control]
Protein
Sample

β-actin

BMP2

Col 1

FN

OPN

laminin

Ki-67

SOX9

TGF-β1

β-tubulin

vimentin

1g

100.0
± 7.5

100.0
± 13.6

100.0
±
10.4

100.0
± 18.8

100.0
± 16.6

100.0
± 13.2

100.0
± 14.8

100.0
± 27.3

100.0
± 20.1

100.0
± 8.2

100.0
± 6.9

AD

105.8
± 12.9

86.5
± 5.4

91.4
± 5.2

139.2
± 19.2

N154.4
± 13.2

110.7
± 11.1

107.8
± 9.1

75.3
± 17.0

N312.1
± 41.4

H59.7
± 23.9

107.4
± 29.3

MCS

83.2
± 10.4

H55.7
± 3.2

H68.8
± 1.1

N186.9
± 19.1

H19.4
± 7.5

H72.1
± 7.7

H67.5
± 6.5

80.9
± 3.7

N345.9
± 30.4

H44.3
± 5.6

H21.5
± 6.3

1g

100.0
± 13.1

100.0
± 8.8

100.0
± 9.8

100.0
± 13.2

100.0
± 24.6

100.0
± 7.6

100.0
± 7.5

100.0
± 9.6

100.0
± 27.3

100.0
± 11.3

100.0
± 19.2

AD

84.8
± 8.0

N196.9
± 13.6

N148.1
±
11.1

N146.9
± 18.0

N2852.2
± 964.4

83.5
± 7.6

H75.3
± 12.0

79.6
± 10.8

H15.5
± 2.4

N188.8
± 18.0

69.3
± 4.3

MCS

103.9
± 11.7

H16.9
± 1.0

H25.5
± 2.1

91.0
± 34.3

H14.8
± 17.3

N266.4
± 44.4

N300.8
± 15.9

N125.4
± 12.8

39.8
± 26.0

H35.7
± 3.8

H1.6
± 0.8

7 days

14 days
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Table 1. Cont.
Protein Secretion [% of 1 g Control]
Protein
Sample
7 days

14 days

DKK1

IL-1β

OC

OPG

OPN

SOST

TNF-α

1g

100.0
± 1.4

100.0
± 13.0

100.0
± 32.6

100.0
± 15.3

100.0
± 14.7

100.0
± 7.8

100.0
± 8.7

RPM

98.8
± 2.5

H34.8
± 5.7

112.0
± 47.8

H42.6
± 19.0

N206.7
± 38.1

H49.4
± 16.9

H46.2
± 12.2

1g

100.0
± 6.6

100.0
± 11.2

100.0
± 24.9

100.0
± 26.2

100.0
± 14.8

100.0
± 32.6

100.0
± 7.5

RPM

102.1
± 6.0

125.6
± 13.5

N148.9
± 28.0

N154.1
± 22.5

N579.2
± 20.8

74.4
± 21.4

96.0
± 11.0

N significant increase/up-regulation (p < 0.05); H significant decrease/down-regulation (p < 0.05).
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In accordance with F-actin, the tubulin distribution was well-organized, as expected, in the 1 g
samples (Figure 3E). In the 7 days RPM samples, an elevated amount of tubulin protein was found in
the 3D aggregates and a more intense fluorescence in the RPM-AD samples (Figure 3F).
In addition, the tubulin microtubule expression was similar in the 1 g controls (Figure 3G).
The 14 days MCS revealed holes in the tubulin cytoskeleton of the MCS samples (Figure 3H). The TUBB
mRNA levels were significantly increased in both 7 days RPM samples; whereas, after 14 days, TUBB
remained significantly elevated in the RPM-AD samples (Figure 3J, Table 1). Moreover, we determined
the VIM mRNA expression by qRT-PCR (Figure 3K), which mirrored the TUBB gene expression.
A significant elevation of VIM mRNA was measured in all 7 days RPM samples; whereas, after 14 days,
VIM was up-regulated in RPM-AD samples (Figure 3K, Table 1). Similar data were obtained by Western
blot analyses of the corresponding proteins (Figure 3L–N; Table 1).
The cell adhesion and extracellular matrix protein laminin connects the cytoskeletal filaments,
through
transmembrane
integrin receptors, with the extracellular matrix [42]. As expected,
Int. J. Mol. Sci.
2019, 20, x
8 ofthe
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majority of the anti-laminin positive ECM material was detectable in the cellular membranes of the
hFOB 1.19 cells (Figure 4A–D). A moderate increase in laminin deposition was noticeable after 7 days
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days and 14 days. No change was detectable in the MCS samples (Figure 4F, Table 1).
In accordance with the morphological data, COLA1A gene expression was up-regulated in cells
exposed to the RPM for 14 days. After 7 days RPM exposure, no significant change was detectable,
compared with the 1 g controls (Figure 4G, Table 1).
To investigate alterations in the ECM secretion of the hFOB 1.19 cells more deeply, we assessed
the SPP1 gene expression and the intracellular amount of protein, respectively (Figure 4H,L). The
SPP1 (i.e., the osteopontin coding gene) gene expression was significantly up-regulated in both the 7
days RPM samples and 14 days RPM samples, compared to corresponding 1 g controls. (Figure 4H,
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In accordance with the morphological data, COLA1A gene expression was up-regulated in cells
exposed to the RPM for 14 days. After 7 days RPM exposure, no significant change was detectable,
compared with the 1 g controls (Figure 4G, Table 1).
To investigate alterations in the ECM secretion of the hFOB 1.19 cells more deeply, we assessed
the SPP1 gene expression and the intracellular amount of protein, respectively (Figure 4H,L). The SPP1
(i.e., the osteopontin coding gene) gene expression was significantly up-regulated in both the 7 days
RPM samples and 14 days RPM samples, compared to corresponding 1 g controls. (Figure 4H, Table 1).
2.3. Changes in BMP2/TGF-β Signalling Pathways
TGF-β/BMP2 signalling has an effect on several different cellular processes. Their important
functions for osteogenesis in mammals are widely accepted [44]. TGF-β1 promotes bone matrix
Int. J. Mol. Sci. 2019, 20, x
9 of 25
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through
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expressed
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It is known that BMPs influence Wnt signalling in bone remodelling through Dkk1 and
2.4.
Secretion
of Soluble
Factors
in the Supernatant
SOST
[44]. A
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regulated
bone mass, through increased osteoclastogenesis caused by
increased RANKL-signalling, due to reduced Wnt-signalling by increased Sost concentrations, has
Differentiation of osteoblast precursor cells to osteoblasts is inhibited by TNF-α [48].
already been elucidated in an animal model [47].
Additionally, TNF-α acts as an inflammatory cytokine in several skeletal diseases [49]. In our study,
the TNF-α secretion was reduced in 7 days RPM samples but remained stable after 14 days (Figure
6A, Table 1).
Besides TNF-α, IL-1β is known as a classical mediator of acute inflammation. In general, IL-1β
is known to attenuate bone formation and reduce osteoblastogenesis [50]. IL-1β secretion was
significantly decreased in the supernatant of osteoblasts exposed for 7 days to the RPM, compared to
the 1 g controls. In contrast, a 14 days RPM exposure induced the release of IL-1β, as compared to the
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2.4. Secretion of Soluble Factors in the Supernatant
Differentiation of osteoblast precursor cells to osteoblasts is inhibited by TNF-α [48]. Additionally,
TNF-α acts as an inflammatory cytokine in several skeletal diseases [49]. In our study, the TNF-α
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Western blotting). Figure 7A represents the interaction analysis as a network of interacting proteins,
We employed Pathway studio v11 to probe the linkage between the proteins detected
such as the bone markers OPG (TNFRSF11B). In vivo OPG binds RANKL and blocks its interaction
experimentally, either in the supernatant (by Luminex technology) or within the cells (measured
with RANK [53]. The binding may be inhibited by collagen 1α1 [54], while TNF-α enhances the
by Western blotting). Figure 7A represents the interaction analysis as a network of interacting proteins,
concentration of both proteins [55]. In addition, sclerostin (SOST) and the bone morphogenic protein
such as the bone markers OPG (TNFRSF11B). In vivo OPG binds RANKL and blocks its interaction
2 (BMP2) have an influence on the RANKL/OPG system. However, SOST inhibits vimentin and βwith RANK [53]. The binding may be inhibited by collagen 1α1 [54], while TNF-α enhances the
actin through DKK1 [56], while elevating the expression of SOX9 [57]. Additional central points of
the overall network are laminin α, fibronectin and TGF-β1 [58]; as well as osteopontin, which interacts
with vimentin [59] and fibronectin [60]. Figure 7B presents a mutual interaction of the expression of
the genes, investigated by qRT-PCR and shown in Figures 3I–K, 4E–H, 5A–D and in Table 1.
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concentration of both proteins [55]. In addition, sclerostin (SOST) and the bone morphogenic protein 2
(BMP2) have an influence on the RANKL/OPG system. However, SOST inhibits vimentin and β-actin
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3. Discussion
3. Discussion
In the present study, we investigated human foetal osteoblasts (hFOB 1.19 cell line), either

In the present study, we investigated human foetal osteoblasts (hFOB 1.19 cell line), either exposed
exposed to the RPM or cultivated under static 1 g conditions for 7 days and 14 days, respectively.
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have been
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[1,24,27–32,61–63]. These techniques had been applied to culture multicellular cancer spheroids from
thyroid cancer cells (FTC-133 [17,25], ML-1 [11,24] and RO82-W-1 [24] cells), breast cancer cells
(MDA-MB-231 [13,61,63] or MCF7 [22,23,64]), cartilage tissue pieces (human chondrocytes [28,29],
primary sheep chondrocytes [62]) and 3D aggregates from stem cells [1,61,63], endothelial cells
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using different methods, such as the RPM, RWV, 2D-clinostat or magnetic levitation, have been
made [1,24,27–32,61–63]. These techniques had been applied to culture multicellular cancer spheroids
from thyroid cancer cells (FTC-133 [17,25], ML-1 [11,24] and RO82-W-1 [24] cells), breast cancer cells
(MDA-MB-231 [13,61,63] or MCF7 [22,23,64]), cartilage tissue pieces (human chondrocytes [28,29],
primary sheep chondrocytes [62]) and 3D aggregates from stem cells [1,61,63], endothelial cells [26,27,61]
and others [61]. These new methods offer new applications in tissue engineering and 3D bioprinting, are
important for drug targeting and discovery and show potential in the field of cancer research [1,20,35].
Practical applications need further improvement, however, which may be achieved by discovering
possibilities for intervening the process, as we have shown for the cells of the MCF7 cell line [23,64].
Therefore, we investigated the underlying mechanisms involved in the development of the spheroids.
We focused on cytoskeletal changes (F-actin microfilaments and tubulin microtubules), the ECM and
the growth and multicellular spheroid formation of the hFOB 1.19 cells when subjected to the RPM
or to 1 g conditions. In addition, we studied the expression of genes coding for proteins involved in
cell structure, shape, migration, adhesion or angiogenesis and hence which might play a role in the
cellular capacity to sense gravitational alterations and the development of MCS, demonstrated with
FTC-133 follicular thyroid cancer cells or MCF-7 breast cancer cells [17,21,22].
Interestingly, we observed that a minor fraction of the hFOB 1.19 cells grew in the form of 3D
constructs or MCS after 7 days RPM exposure.
Applying the experimental design, described in the material and methods section, which was
based on recent experience with culturing the FTC-133 thyroid and MCF7 breast cancer cells, as well as
endothelial cells under real and simulated microgravity [17,21,22,26,27], we repeatedly detected that
hFOB 1.19 cells developed into two phenotypically different populations; one subpopulation remaining
adherent to the bottom of the culture flask (the RPM-AD monolayer) and another subpopulation that
formed MCS, freely floating in the cultivation medium. The number and size of the MCS increased after
14 days RPM exposure (Figure 1), suggesting that the reduced gravity conditions provided by the RPM
promoted the development of MCS and 3D growth, even if no scaffold was present—as demonstrated
earlier with the help of an RCC, using human embryonic palatal mesenchymal pre-osteoblasts [65].
The MCS contained numerous cells and ECM deposition was evident at both 7 days and 14 days, along
the surface of the tissue-engineered construct. The construct (MCS) size and number changed with
time, particularly between 7 days and 14 days (see Figure 1). Constructs appeared to be confluent
with cells at 14 days, both at the periphery and centre of the construct. As demonstrated in Figure 2,
an accumulation of ECM proteins was detectable with time, as well as calcification areas, which were
visible after 14 days (as demonstrated by the von Kossa and Alcian blue stains).
F-actin staining revealed increases in F-actin at the cellular membranes of the MCS after 7
days and 14 days. Actin, tubulin and vimentin are key components of the cytoskeleton and
have various functions [66,67]. They play an important role in the perception of exterior signals,
including the gravitational force [66]. Notably, cytoskeletal alterations have been detected in cell lines
derived from various cell types, such as lymphocytes, glial cells, endothelial cells, cancer cells and
others [11,12,14,21–23,26,28]. Unfortunately, studies investigating the cytoskeleton in r-µg and s-µg, so
far, are based on the analysis of fixed cells. Live cell imaging of FTC-133 cancer cells expressing the
Lifeact-GFP marker protein for the visualization of F-actin under real microgravity during a TEXUS
sounding rocket mission and a parabolic flight mission using a compact fluorescence microscope
(FLUMIAS) confirmed the results obtained with fixed cells [18].
During the TEXUS rocket flight, well-structured filament bundles were found in FTC-133 thyroid
cells, as well as stress fibres, together with filopodia- and lamellipodia-like structures and cell
detachment [18]. These experiments, performed in s-µg and r-µg, revealed clear changes in morphology,
cytoskeleton and function. Studies on microtubules in altered gravity conditions have shown that they
are also gravity-sensitive [67].
In this study, we detected similar cytoskeletal changes of F-actin at the outer cellular membrane
after both 7 days and 14 days (see Figure 3). Moreover, we found up-regulated ACTB, TUBB and VIM
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in the AD and MCS samples after 7 days RPM exposure. VIM was significantly down-regulated after
14 days in the RPM-AD samples. The TUBB gene expression level of the 1 g samples was similar to
that of the MCS group (Figure 3).
The 1 g control samples, grown in T25 culture flasks, multiplied as a monolayer and never
formed any MCS. In contrast, hFOB 1.19 cells exposed to the RPM presented 3D growth. Histological
investigation of these constructs showed both round and irregularly-formed structures, with a uniform
cellular distribution throughout the constructs at 7 days and 14 days (Figures 1 and 2). An external
layer (or capsule) of cells developed on the surface of the constructs, becoming more prominent
with time. There was no histological difference between 7 days or 14 days-RPM exposure. Sirius
red staining revealed an ECM deposition in the MCS, detectable at both 7 days and 14 days. The
ECM was composed of ECM proteins secreted by the cells, thereby providing important structural,
mechanical and biochemical support to the surrounding cells [68]. We observed several alterations
in the components of the ECM. The gene expression of SPP1 was clearly up-regulated in all RPM
samples. The FN1 mRNA expression was significantly elevated in AD cells, compared to 1 g, whereas
no changes were found in MCS. Collagen type 1 is a marker for early stage osteogenesis, which was
expressed in all cultured constructs. The COL1A1 mRNA was not significantly altered in the 7 days
samples but was significantly elevated in the 14 days samples. In contrast, LAMA1 was significantly
up-regulated in all 7 days RPM samples but was not altered in the 14 days samples.
In accordance with these findings, CLSM analysis revealed an apparent increase in laminin in
the cells exposed to the RPM, compared to the 1 g controls. Even though CLSM is not a quantitative
method, the obtained images indicated an overall increase in anti-laminin-positive signals in the RPM
samples, compared with the 1 g controls. Moreover, the CLSM images also demonstrated that F-actin
and laminin were accumulated at the cell boundaries and in the extracellular space around the MCS,
which corresponds well to earlier findings on different types of cells such as glial cells, lymphocytes
(Jurkat) and FTC-133 thyroid cancer cells [12,14,18].
Bone morphogenetic protein 2 (BMP-2) belongs to the TGF-β superfamily; it is involved in
cartilage and bone development and has demonstrated an osteo-inductive effect [69,70]. Patients
receiving exogenous BMP-2 to treat bone fractures or defects exhibited elevated sera levels of TNF-α
and IL-1β, which may affect the outcome of bone regeneration [50]. BMP2 gene expression was
significantly reduced in RPM AD cells after both 7 days and 14 days. In 7 days samples, BMP2 was
elevated in MCS, compared to 1 g, indicating BMP2 playing a role in early bone formation, in this
experimental setting.
Transforming Growth Factor β1 (TGF-β1) has been shown to influence cell attachment of bone
cells of the line MG-63 [71]. TGF-β1 is involved in the regulation of cell proliferation, differentiation
and growth [44]. In addition, it is linked with embryogenesis, tissue repair and bone regulation [44].
There was a trend of increased TGFB1 mRNA levels in the 7 days RPM samples. We measured a
significantly elevated TGFB1 mRNA level in the 14 days RPM-AD cells, compared to the 1 g samples.
Pathway analyses (Figure 7) revealed interactions between TGFB1 and LAMA1, as well as between
TGFB1 and FN1. TGF-β1 is known to enhance ECM deposition in several tissues.
The SRY HMG box-related gene 9 (SOX9), which plays an important role in normal skeletal
development, was up-regulated in both the 7 days- and 14 days-RPM-AD cell samples, as compared to
the 1 g samples. No change was found in the MCS. The BMP2, TGFB1 and SOX9 proteins are involved
in chondrogenic and osteogenic differentiation [72].
In summary, the mRNAs of BMP2, TGFB1 and SOX9 were affected in foetal osteoblasts exposed
to s-µg. This was similar to earlier studies, which demonstrated the positive influence of these factors
on human chondrocytes exposed to parabolic flight manoeuvres [73]. The relevant proteins, such as
BMP-2, represent growth and differentiation factors regulating the chondrocyte development through
a complex mutual regulation [74]. The products of TGFB1 and SOX9, together with BMP-2, drive
development from mesenchymal stem cells toward cartilage-forming chondrocytes [75]. This progress
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appears to be supported, because BMP-2, TGFB1 and SOX9 gene expression and protein content were
enhanced after 31 parabolic manoeuvres [73].
We also focused on the MKI67 mRNA expression, which was not significantly altered in all samples,
while the Ki-67 antigen was clearly enhanced in the 14 days RPM-MCS cell samples (Figure 5H)
indicating that this group had an enhanced proliferation behaviour in the experimental setting.
We further investigated the secretion of the cytokines involved in bone formation from hFOB cells.
The release of dickkopf-related protein 1 (DKK1) in the cell supernatant was unchanged after 7 days
and 14 days, between both control and RPM samples but the hFOB cells revealed a time-dependent
reduction of the protein after 14 days, compared to 7 days. DKK1 is a secreted Wnt inhibitor that binds
LRP5 and LRP6 during embryonic development. There is evidence that a reduction in DKK1 elevates
Wnt activity and induces a high bone mass phenotype. Reduced levels of DKK1 remove suppression
of bone formation and prevent the development of osteolytic bone diseases. Targeting DKK1 might
have therapeutic significance for the treatment of low bone-mass diseases [76].
Furthermore, a key signalling factor controlling bone resorption and bone formation is the receptor
activator of nuclear factor-κB (RANK)/RANK ligand/osteoprotegerin [77]. Osteoprotegerin (OPG) is
a cytokine receptor, which also belongs to the tumour necrosis factor (TNF) receptor superfamily.
Pro-inflammatory cytokines, extracellular matrix proteins and bone-regulating cytokines of the
RANKL/OPG and Wnt/β-catenin pathways are mandatory for normal bone repair [78].
The OPG level was reduced after 7 days in RPM samples, as compared to the controls. In contrast,
after 14 days, the secretion of OPG was significantly elevated and further enhanced by RPM exposure.
Osteocalcin (OC), also called bone gamma-carboxyglutamic acid-containing protein (BGLAP),
is synthesized by osteoblasts and is involved in the metabolic regulation. OC acts as a pro-osteoblastic
(anabolic) factor and is important for bone formation. Furthermore, it has also been implicated in bone
mineralization and calcium ion homeostasis [79].
OC secretion remained stable after a 7 days exposure to the RPM and in the 1 g control osteoblasts.
In contrast, the release of OC was significantly elevated in 14 days RPM-exposed osteoblasts, as
compared to static controls. These results fit well to the finding that, after 14 days, the bone tissue
constructs were increased in both number and size. The pathway analysis revealed that OC interacted
with SPP1.
Osteopontin is also known as secreted phosphoprotein 1 (SPP1). It is an extracellular structural
protein and, therefore, an organic bone component. It is also detectable in various cell types
(e.g., FTC-133 follicular thyroid cancer cells and EA.hy926 endothelial cells) and has been shown
to be altered by microgravity conditions [25,27,80].
We measured the osteopontin (SPP1) gene expression and found that SPP1 mRNA was
significantly elevated after both 7 days and 14 days in the RPM samples, as compared to the static
controls. This finding is in agreement with data obtained from thyroid cancer cells and endothelial
cells, which both showed elevated SPP1 mRNAs after RPM exposure [25,27,80].
Sclerostin (SOST) is produced by osteocytes and has anti-anabolic effects on bone formation;
inhibition of SOST can stimulate bone formation [81]. The SOST secretion was significantly reduced
after 7 days in the RPM samples, as compared to the 1 g controls.
After 14 days, the cells secreted unaltered levels of SOST in the supernatant. This indicates that,
initially, microgravity inhibits SOST and stimulates bone formation, but, after 14 days, microgravity
did not support bone formation through this mechanism any longer.
Pro-inflammatory cytokines are important for bone formation and bone repair [78] and, therefore,
we measured the secretions of IL-1β and TNF-α in the supernatant.
The cytokine interleukin-1β (IL-1β) is an important mediator of the inflammatory response and
is involved in several biological processes, such as proliferation, differentiation and apoptosis [82].
The induction of cyclooxygenase-2 (PTGS2/COX2) by this cytokine in the central nervous system
is found to contribute to inflammatory pain hypersensitivity [83]. The release of IL-1β decreased
significantly after 7 days in RPM samples, as compared to the 1 g controls. After 14 days, foetal
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osteoblasts in the RPM samples released increased amounts of the IL-1β protein, as compared to the
1 g controls. The amount of released IL-1β was significantly higher after 14 days, compared to the
amounts after 7 days.
Furthermore, we investigated the release of tumour necrosis factor alpha (TNF-α), which is
a cytokine involved in the regulation of a wide spectrum of biological processes, including cell
proliferation, differentiation, apoptosis, lipid metabolism and coagulation [84].
The release of TNF-α decreased after 7 days in RPM samples, as compared to the static 1 g controls.
After 14 days, the hFOB cells of both groups only secreted a low and unaltered amount of TNF-α in
the supernatant.
Taken together, these in vitro tissue-engineered bone constructs provide an accurate system for
investigating the molecular signaling pathways involved in normal bone formation and remodeling
processes and could be also used for co-cultures with osteoclasts. Additionally, as an in vitro system, it
has the potential of reducing animal experiments, for instance as an alternative method for testing the
effects of pharmaceutical agents or biochemical stimuli. Moreover, these bone constructs can be used
for investigating bone-related diseases. Patients having plastic and/or reconstructive surgery with
traumatic bone defects or osteonecrosis could benefit from this approach in the future.
4. Materials and Methods
4.1. Cell Culture
The cell culture model used was represented by a human foetal osteoblast cell line, hFOB 1.19
(catalogue number CRL-11372; American Type Culture Collection, Manassas, VA, USA), which is a
conditionally-immortalized clonal cell line [37]. hFOB 1.19 is immortalized with a gene encoding for a
temperature-sensitive mutant of the SV40 large T antigen (tsA58).
We cultured hFOB 1.19 in a 1:1 mixture of DMEM and Ham’s F12 media (Lonza, Verviers, Belgium)
supplemented with 2.5 mM L-glutamine (without phenol red), 10% foetal bovine serum (Biochrom
AG, Berlin, Germany) and 0.3 mg/mL G418 (Gibco, Life Technologies, Naerum, Denmark). The cells
were seeded in 75 cm2 ventilated cell culture flasks (Sarstedt AG, Nümbrecht, Germany) under the
standard conditions of 37 ◦ C and 5% CO2 , as previously described [21–23].
Cells in the third to fifth passage were used in the subsequent experiments. For RPM experiments,
hFOB 1.19 cells were seeded into 25 cm2 ventilated cell culture flasks (Sarstedt AG) and given at least
24 h to properly attach to the bottom of the flasks, forming an adherent monolayer (AD). Subsequently,
the flasks were completely filled with the supplemented medium. The experiment ended with the
fixation of cells assigned to s-µg or controls, as described earlier [21–23]. For 14 days experiments,
a 50% medium exchange by aspiration was necessary after 7 days, to ensure proper concentrations of
nutrients and waste products. The remaining MCS were retrieved by upright positioning of flasks,
leading to MCS sedimentation.
4.2. Random Positioning Machine
Microgravity conditions were simulated using a desktop RPM (Airbus Defence and Space, former
Dutch Space, Leiden, The Netherlands) [2]. The RPM rotates a central frame around two perpendicular
axes, randomly changing the direction of rotation and the angular velocity, in the range between 60◦ /s
and 75◦ /s, in both axes (Figure 8). It was used in the real random mode. Thereby, the direction of the
gravitational acceleration affecting the samples was continuously randomized and the magnitude of the
net gravitational vector approached zero over time, producing a simulated state of microgravity [4,7].
The RPM was placed inside a commercial incubator, under standard conditions at 37◦ C and 5% CO2 ,
with up to twelve 25 cm2 flasks fixed to the central frame. The flasks were placed no further than
7.5 cm from the centre of rotation.
All 25 cm2 flasks were completely filled with medium, minimizing shear stress. The samples
were run on the RPM for 7 days and 14 days, while an equivalent number of 25 cm2 flasks, also
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completely filled with medium, were placed in the same incubator, to serve as 1 g controls to the RPM
samples
[21–23].
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4.3. F-Actin, Tubulin and Laminin Staining
4.3. F-Actin, Tubulin and Laminin Staining
For F-actin, laminin and tubulin staining, 5 × 105 cells were seeded in 60 Nunc™ LAB-TEK™
For F-actin, laminin and tubulin staining, 5 × 105 cells were seeded in 60 Nunc™ LAB-TEK™
slide flasks (nr. 170920, material: polystyrene, Fisher Scientific, Roskilde, Denmark).
slide flasks (nr. 170920, material: polystyrene, Fisher Scientific, Roskilde, Denmark).
The attached cells were cultured for 7 days or 14 days, respectively, on the RPM (n = 30) or next to
The attached cells were cultured for 7 days or 14 days, respectively, on the RPM (n = 30) or next
the RPM, acting as 1 g controls (n = 30) in the same incubator. The slide flasks were filled completely
to the RPM, acting as 1 g controls (n = 30) in the same incubator. The slide flasks were filled completely
and made air bubble free with medium.
and made air bubble free with medium.
For the 14 days experiment, 50% of the medium in the cultivation flasks was carefully aspirated and
For the 14 days experiment, 50% of the medium in the cultivation flasks was carefully aspirated
exchanged with fresh medium after 7 days. After 7 days or 14 days of cultivation, the cells were washed
and exchanged with fresh medium after 7 days. After 7 days or 14 days of cultivation, the cells were
twice with DPBS (Life Technologies™, Carlsbad, CA, USA) and fixed, with 4% paraformaldehyde and
washed twice with DPBS (Life Technologies™, Carlsbad, CA, USA) and fixed, with 4%
70% methanol, for 30 min. After fixation, the cells were permeabilized with a Triton-X-100 (Merck,
paraformaldehyde and 70% methanol, for 30 min. After fixation, the cells were permeabilized with a
Darmstadt, Germany) and, subsequently, washed twice with DPBS.
Triton-X-100 (Merck, Darmstadt, Germany) and, subsequently, washed twice with DPBS.
Laminin and tubulin were visualized by immunofluorescence, using primary antibodies against
Laminin and tubulin were visualized by immunofluorescence, using primary antibodies against
laminin (1:25, L9393, Merck) and tubulin (1:500, T5293, Merck).
laminin (1:25, L9393, Merck) and tubulin (1:500, T5293, Merck).
After the primary antibody incubation for 24 hours at room temperature, the cells were washed
After the primary antibody incubation for 24 hours at room temperature, the cells were washed
twice with DPBS. Subsequently, the samples were incubated with anti-rabbit (laminin) or anti-mouse
twice with DPBS. Subsequently, the samples were incubated with anti-rabbit (laminin) or anti-mouse
(tubulin) secondary antibodies, conjugated to an Alexa Fluor 488 (1:500, 4412S and 4408S, both Cell
(tubulin) secondary antibodies, conjugated to an Alexa Fluor 488 (1:500, 4412S and 4408S, both Cell
Signalling Technology, Danvers, MA, USA).
Signalling Technology, Danvers, MA, USA).
F-actin was visualized by means of rhodamine-phalloidin staining (Molecular Probes®
, Eugene,
F-actin was visualized by means of rhodamine-phalloidin staining
(Molecular Probes®, Eugene,
OR, USA). For the detailed method, see [26]. Fluoro-shielding with 40 , 6-diamidino-2-phenylindole,
OR, USA). For the detailed method, see [26]. Fluoro-shielding with 4’, 6-diamidino-2-phenylindole,
DAPI, (Sigma) was used for nuclear counterstaining and mounting in all samples, before subsequent
DAPI, (Sigma) was used for nuclear counterstaining and mounting in all samples, before subsequent
imaging by confocal laser scanning microscopy (CLSM) [26,85].
imaging by confocal laser scanning microscopy (CLSM) [26,85].
4.4. Microscopy
4.4. Microscopy
Phase contrast microscopy was performed before and after the RPM experiments, to ensure
Phase contrast microscopy was performed before and after the RPM experiments, to ensure
viability and determine the morphological changes of the cells. Pictures were taken using a Canon
viability and determine the morphological changes of the cells. Pictures were taken using a Canon
EOS 550D camera (Canon GmbH, Krefeld, Germany) through a Leica DM IL LED inverted microscope
EOS 550D camera (Canon GmbH, Krefeld, Germany) through a Leica DM IL LED inverted
(Leica Microsystems, Wetzlar, Germany). Fluorescence staining was analysed using a Zeiss LSM
microscope (Leica Microsystems, Wetzlar, Germany). Fluorescence staining was analysed using a
710 CLSM (Zeiss, Jena, Germany) fitted with a Plan-Apochromat 63 × 1.4 objective, as previously
Zeiss LSM 710 CLSM (Zeiss, Jena, Germany) fitted with a Plan-Apochromat 63 × 1.4 objective, as
described [26,85]. Excitation and emission wavelengths for the Alexa Fluor 488 were λex = 488 nm and
previously described [26,85]. Excitation and emission wavelengths for the Alexa Fluor 488 were λex =
λem = 525 nm, respectively. Correspondingly, for the TRITC: λex = 532 nm and λem = 576 nm.
488 nm and λem = 525 nm, respectively. Correspondingly, for the TRITC: λex = 532 nm and λem = 576
nm.
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4.5. RNA Isolation
The cells were removed from the culture flasks with scrapers and transferred immediately to
tubes for isolation by centrifugation at 3400× g for 10 min at 4 ◦ C. Total RNA was extracted using
an AllPrep RNA/Protein Kit (Qiagen GmbH, Hilden, Germany), according to the manufacturer’s
instructions. RNA concentrations and quality were determined spectrophotometrically at 260 nm with
a SpectraMax M2 Microplate Reader (Molecular Devices, Sunnyvale, CA, USA).
The isolated RNA had an A260/A280 ratio of >1.5. The cDNA for quantitative PCR was
obtained using a First-Strand cDNA Synthesis Kit (Fisher Scientific), according to the manufacturer’s
instructions.
4.6. Quantitative Real Time PCR
Quantitative real-time PCR (qRT-PCR) was used to determine the expression levels of target
genes [21–23,26]. Appropriate primers (overview given in Table 2) were designed using the Primer
express software (Applied Biosystems, Darmstadt, Germany) with a Tm of 60◦ C, taking care of the
exon-exon boundaries. All primers were synthesized by TIB Molbiol (Berlin, Germany). The cDNA
analysis was performed using a 7500 Fast Real-Time PCR System with Fast SYBR Master Mix (both
from Applied Biosystems). The final reaction volume was 12.5 µL, including 1 µL template cDNA
and a primer concentration of 500 nM. PCR conditions were as follows: 20 s at 95 ◦ C, 40 cycles
of 3 s at 95 ◦ C, 1 min at 60 ◦ C, followed by a melting curve analysis, with a temperature gradient
from 60 ◦ C to 95 ◦ C in 0.3 ◦ C increments. If all amplicons showed a Tm similar to the one predicted
by the Primer Express software, the PCR reaction was considered to be specific. Each sample was
measured in triplicate. Relative transcription levels were quantified using the comparative CT (∆∆CT )
method. The transcription level of the housekeeping gene 18S rRNA was used as a reference gene for
data normalization.
Table 2. Primers used for qRT-PCR.
Gene

Primer Name

Sequence

18S rRNA

18S-F
18S-R
ACTB-F
ACTB-R
BMP2-F
BMP2-R
COL1A1-F
COL1A1-R
FN1-F
FN1-R
LAMA1-F
LAMA1-R
MKI67-F
MKI67-R
SOX9-F
SOX9-R
SPP1-F
SPP1-R
TATA-F
TATA-R
TGFB1-F
TGFB1-R
TUBB-F
TUBB-R
VIM-F
VIM-R

GGAGCCTGCGGCTTAATTT
CAACTAAGAACGGCCATGCA
TGCCGACAGGATGCAGAAG
GCCGATCCACACGGAGTACT
GACCTGTATCGCAGGCACTCA
TCGTTTCTGGTAGTTCTTCCAAAGA
ACGAAGACATCCCACCAATCAC
CGTTGTCGCAGACGCAGAT
TGAGGAGCATGGTTTTAGGAGAA
TCCTCATTTACATTCGGCGTATAC
TGCTCATGGTCAATGCTAATCTG
TCTATCAATCCTCTTCCTTGGACAA
TGGGGAAAGTAGGTGTGAAAGAAG
CTCCTTAAACGTTCTGATGCTCTTG
TTGAGACCTTCGACGTCAATGAG
TCTGGCCACGAGTGGCC
CGAGGTGATAGTGTGGTTTATGGA
CGTCTGTAGCATCAGGGTACTG
GTGACCCAGCATCACTGTTTC
GCAAACCAGAAACCCTTGCG
CACCCGCGTGCTAATGGT
AGAGCAACACGGGTTCAGGTA
CTGGACCGCATCTCTGTGTACTAC
GACCTGAGCGAACAGAGTCCAT
TTCAGAGAGAGGAAGCCGAAAAC
AGATTCCACTTTGCGTTCAAGGT

ACTB
BMP2
COL1A1
FN1
LAMA1
MKI67
SOX9
SPP1
TBP
TGFB1
TUBB
VIM

All sequences are given in 50 –30 direction.
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All samples were measured in triplicate and normalized to the housekeepers 18S mRNA and TBP.
The 7 days 1 g samples were set as 100%.
4.7. Determination of Intracellular Protein Levels
Western blot analyses, including gel electrophoresis, trans-blotting and densitometry, were
performed following routine protocols, as described previously [64,86]. Primary antibodies for protein
detection and used dilutions are listed in Table 3. All samples were normalized to the housekeeper
protein cyclophilin.
Table 3. Antibodies used for Western blot analyses.
Antibody Target

Company/No

Host

Size (kDa)

Used Dilution

β-actin
BMP2
Collagen I
Cyclophilin
Fibronectin
Ki-67
Laminin
Osteopontin
SOX9
TGF-β1
TNF-α
β-tubulin
Vimentin

Sigma/A5316
Novus biological/
Sigma/C2456
Abcam/AB178397
Invitrogen/MA1198
Santa cruz/c-15402
Invitrogen/PA1-1673
Sigma/07264
Abcam/ab26414
Abcam/ab92486
Abcam/ab9739
Sigma/T5293
Sigma/WH0007431

Ms
Rb
Ms
Rb
Ms
Rb
Rb
Rb
Rb
Rb
Rb
Ms
Ms

42
44
~130
20
250
250
~200
50
56
44
26
50
~53

1:2000
1:500
1:500
1:2000
1:1000
1:200
1:1000
1:1000
1:1000
1:500
1:500
1:1000
1:1000

Ms: mouse, Rb: rabbit.

4.8. Measurement of Secreted Bone Biomarkers
Multi-analyte profiling of the protein levels in the cell culture medium of primary human
osteoblasts was performed on the Luminex 200 system (Luminex, Austin, TX, USA), using xMAP
technology. Acquired fluorescence data were analysed by the xPONENT 3.1 software (Luminex).
The effect of adiponectin on the secretion of bone markers in the culture medium was measured using
the Milliplex Human. The effects of RPM on the secretion of bone markers in the culture medium was
measured using the Milliplex Human Bone Panel (HBNMAG-51K, MILLIPORE Corporation, Billerica,
MA, USA). The assay included analysis of the following secreted biomarkers; adrenocorticotrophic
hormone (ACTH), Dickkopf-1 (Dkk1), interleukin-6 (IL-6), insulin, leptin, tumour necrosis factor alpha
(TNF-α), osteoprotegerin (OPG), osteocalcin (OC), osteopontin (SPP1), sclerostin (SOST), parathyroid
hormone (PTH) and fibroblast growth factor-23 (FGF-23). Multi-analyte profiling of the protein levels
of these factors in the cell culture medium was performed using the Luminex 200 system (Luminex,
Austin, TX, USA), using xMAP technology. Acquired fluorescence data were analysed by applying the
Luminex xPONENT version 3.1.871 or MILLIPLEX™ Analyst version 5.1 software (Luminex).
4.9. Histological Staining
After the 7 days and 14-days RPM culture of the hFOB 1.19 cells, the MCS were collected, three
times carefully washed in PBS and fixed in 4% paraformaldehyde. After paraffin embedding, the MCS
were sectioned with a microtome into 3 µm sections. Haematoxylin and eosin stains were applied,
as described earlier [22]. Sirius red staining was performed to evaluate qualitative collagen content,
as described earlier [87]. All sections were visualized by light microscopy, using an oil-immersion
objective with calibrated magnifications of ×100 and ×200.
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4.10. Determination of Calcification of the MCS
The multicellular spheroids were stained with the von Kossa silver staining technique [88].
The von Kossa stain was used to quantify mineralization in the 3D constructs. In addition, the MCS
were stained with Alcian blue [89] (Sigma, Taufkirchen, Germany) and, subsequently, examined.
For this purpose, the MCS were fixed, for 10 min, with 4% paraformaldehyde (PFA in DPBS), washed
twice with DPBS, stained with a drop of the diluted staining solution (diluted according to the
manufacturer’s instructions), washed twice with DPBS again and mounted with Entellan®(Merck,
Darmstadt, Germany) for further microscopic analysis.
4.11. Pathway Analysis
To investigate the mutual regulation between genes and to visualize the localization and
interactions between proteins, we entered the relevant UniProtKB entry numbers in the Pathway Studio
v.11 software (Elsevier Research Solutions, Amsterdam, The Netherlands). Graphs were generated for
gene expression, protein regulation and binding. The method was described previously [22].
4.12. Statistical Analysis
All statistical analyses were performed using the SPSS 24.0 software (SPSS, Inc., Chicago, IL,
USA). Data are presented as the mean ± SD. Due to the number of samples per group, an estimation
of the data distribution characteristics was not feasible. We, therefore, employed the assumption-less,
non-parametric Mann-Whitney-U test to assess the differences between the experimental groups.
p < 0.05 was considered statistically significant.
5. Conclusions
The hFOB 1.19 cell line has been described as a model cell line for osteogenesis, with an ability to
form mineralized nodules [37]. However, not all studies using the hFOB 1.19 cell line have published
histological investigations [38,90]. Our histological staining identified cell distribution, including
alterations of the cytoskeleton and the extracellular matrix and mineralization in the 3D constructs,
having had up to 14 days of RPM exposure.
The human foetal osteoblasts exposed to the RPM grew as adherent monolayer, as well as in the
form of RPM-derived bone constructs. We have successfully demonstrated the ability of the modelled
microgravity analogue RPM to form 3D constructs and to support human osteogenesis in vitro. Given
these findings, we conclude that hFOB 1.19 constructs show an excellent potential as biomaterial for
human bone-tissue engineering applications.
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